全球虛擬幻燈片設備(WSI)市場 - 成長,趨勢,及預測(2019年 - 2024年)

Global Whole Slide Imaging Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 391481
出版日期 內容資訊 英文 139 Pages
商品交期: 2-3個工作天內
全球虛擬幻燈片設備(WSI)市場 - 成長,趨勢,及預測(2019年 - 2024年) Global Whole Slide Imaging Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年02月01日內容資訊: 英文 139 Pages




第1章 簡介

  • 研究的成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
  • 市場阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各技術
    • 掃描機
    • IT基礎設施
    • 放映裝置
    • 影像管理系統
  • 各用途
    • 遠隔病理診斷
    • 細胞病理學
    • 免疫組織化學
    • 血液病理
  • 各終端用戶
    • 教育
    • 研究
    • 臨床
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東及非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Olympus Corporation
    • Philips Healthcare
    • Definiens AG
    • Leica Microsystems GmbH
    • Ventana Medical Systems Inc.
    • Nikon Corporation
    • Visiopharm
    • 3Dhistech
    • Hamamatsu Photonics KK
    • Indica Labs
    • Inspirata
    • Mikroscan Technologies Inc.

第7章 市場機會及未來趨勢


Product Code: 46569

Market Overview

The key factors propelling the whole slide imaging market are increasing usage in drug discovery processes, technological advancements in whole slide imaging, and rising popularity of virtual slides, as compared to physical slides. Also, the increasing incidence of cancer is expected to drive the growth of the overall market.

With increasing research, there are many pharmaceutical and biotech companies that have made significant investments in drug discovery. As a consequence, imaging is now performed in all drug discovery processes. Therefore, imaging and image-based technologies are now commonplace across the drug discovery workflow and hold great promise for R&D, allowing researchers to understand and work with model organisms. Thus, it is expected to improve standardization, quality, and manageability of research, and help reduce costs. Thus, as research in drug discovery increases, it is expected to directly impact the growth of the whole slide imaging market.

Digital pathology (DP) is also a rapidly growing field that has generated a lot of interest among hospitals, laboratories, surgeons, research institutes, and healthcare companies, among others. The digital pathology process is expected to significantly increase, and thereby, increase productivity and efficiency, by allowing pathologists to stay in their offices rather than travel to numerous locations.

With the advancement of digital pathology and computer-assisted artificial intelligence technology, it is inevitable that digital health will come to play an important role in the strategic planning of cancer research and precision medicine delivery.

Thus, whole slide imaging devices are increasingly being used for cancer research and precision medicine, as many diseases can be defined by being examined under the microscope. Pathologists' involvement in precision medicine and digital technology is likely to be a key driver for improving patient care. As a result, this is a great opportunity for the growth of the market.

Scope of the Report

As per the scope of the report, whole slide imaging involves physical slides, which are transformed into digital resources that can be analyzed on any computer, easily stored, and quickly shared with colleagues wherever they are. It refers to the scanning of conventional glass slides, in order to produce digital slides, and is the most recent imaging modality being employed by pathology departments, worldwide.

Key Market Trends

Immunohistochemistry Application Segment is Expected to Grow the Fastest During the Forecast Period

Immunohistochemistry (IHC) is a method for detecting antigens or haptens in the cells of a tissue section, by using the principle of antibodies binding specifically to antigens in biological tissues. It is a widely used technique in pathology to observe protein expression in tissue samples. It is also gaining importance, as many biotech companies use immunohistochemistry in early research and later stage drug development. Thus, with more advanced processes, this method helps in faster assessment of samples.

There has also been increased use of whole slide imaging to study blood coagulation disorders to hematopoietic neoplasms. Although there has been increased interest by pharmaceutical companies to use WSI products to develop biomarkers, the acceptance of digitized images in clinical validation studies by regulatory authorities still remains a challenge.

The Asia-Pacific Market Holds the Fastest Growth, and is Expected to Follow the Same Trend over the Forecast Period

The Asia-Pacific market is witnessing the highest CAGR, owing to the same factors responsible for the growth of this market, such as increasing research on drug discovery and awareness about the benefits of WSI. The market for whole slide imaging is growing every year and generating a large number of pathology specimens each year, due to the presence of a large population base. Thus, the adoption rate of whole slide imaging in the region has also increased, and is expected to rise in the same manner over the coming years.

Competitive Landscape

In the last decade, many pharmaceutical and biotech companies made significant investments in imaging in drug discovery. There has also been increased interest by pharmaceutical companies to use WSI products to develop biomarkers, companion, or complementary diagnostics. Many manufacturing companies are, thus, looking for opportunities in different market economies, such as Europe and Canada, where the policies are not as stringent and are better integrated.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Popularity of Virtual Slides as Compared to Physical Slides
    • 4.2.2 Technological Advancements in Whole Slide Imaging
    • 4.2.3 Increasing Research in Drug Discovery
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Approvals
    • 4.3.2 High Cost of Whole Slide Imaging Systems
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Technology
    • 5.1.1 Scanners
    • 5.1.2 IT Infrastructure
    • 5.1.3 Viewer
    • 5.1.4 Image Management System
  • 5.2 By Application
    • 5.2.1 Telepathology
    • 5.2.2 Cytopathology
    • 5.2.3 Immunohistochemistry
    • 5.2.4 Hematopathology
  • 5.3 By End User
    • 5.3.1 Education
    • 5.3.2 Research
    • 5.3.3 Clinical
  • 5.4 Geography
    • 5.4.1 North America
      • United States
      • Canada
      • Mexico
    • 5.4.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.4.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South korea
      • Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • GCC
      • South Africa
      • Rest of Middle East & Africa
    • 5.4.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Olympus Corporation
    • 6.1.2 Philips Healthcare
    • 6.1.3 Definiens AG
    • 6.1.4 Leica Microsystems GmbH
    • 6.1.5 Ventana Medical Systems Inc.
    • 6.1.6 Nikon Corporation
    • 6.1.7 Visiopharm
    • 6.1.8 3Dhistech
    • 6.1.9 Hamamatsu Photonics KK
    • 6.1.10 Indica Labs
    • 6.1.11 Inspirata
    • 6.1.12 Mikroscan Technologies Inc.